Class information for:
Level 1: TIOTROPIUM//INDACATEROL//LONG ACTING MUSCARINIC ANTAGONIST

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4212 1750 34.5 67%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
721 12118 COPD//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//PULMONARY REHABILITATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TIOTROPIUM Author keyword 223 67% 11% 199
2 INDACATEROL Author keyword 158 84% 5% 87
3 LONG ACTING MUSCARINIC ANTAGONIST Author keyword 55 87% 2% 27
4 ACLIDINIUM Author keyword 44 85% 1% 23
5 UMECLIDINIUM Author keyword 35 86% 1% 18
6 ACLIDINIUM BROMIDE Author keyword 35 81% 1% 21
7 IPRATROPIUM Author keyword 33 48% 3% 51
8 RESPIMAT R Author keyword 30 100% 1% 12
9 GLYCOPYRRONIUM Author keyword 28 69% 1% 24
10 OXITROPIUM BROMIDE Author keyword 27 83% 1% 15

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TIOTROPIUM 223 67% 11% 199 Search TIOTROPIUM Search TIOTROPIUM
2 INDACATEROL 158 84% 5% 87 Search INDACATEROL Search INDACATEROL
3 LONG ACTING MUSCARINIC ANTAGONIST 55 87% 2% 27 Search LONG+ACTING+MUSCARINIC+ANTAGONIST Search LONG+ACTING+MUSCARINIC+ANTAGONIST
4 ACLIDINIUM 44 85% 1% 23 Search ACLIDINIUM Search ACLIDINIUM
5 UMECLIDINIUM 35 86% 1% 18 Search UMECLIDINIUM Search UMECLIDINIUM
6 ACLIDINIUM BROMIDE 35 81% 1% 21 Search ACLIDINIUM+BROMIDE Search ACLIDINIUM+BROMIDE
7 IPRATROPIUM 33 48% 3% 51 Search IPRATROPIUM Search IPRATROPIUM
8 RESPIMAT R 30 100% 1% 12 Search RESPIMAT+R Search RESPIMAT+R
9 GLYCOPYRRONIUM 28 69% 1% 24 Search GLYCOPYRRONIUM Search GLYCOPYRRONIUM
10 OXITROPIUM BROMIDE 27 83% 1% 15 Search OXITROPIUM+BROMIDE Search OXITROPIUM+BROMIDE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TIOTROPIUM 134 42% 14% 250
2 OXITROPIUM BROMIDE 77 89% 2% 34
3 TIOTROPIUM BROMIDE 71 64% 4% 69
4 IPRATROPIUM 66 55% 5% 84
5 ONCE DAILY INDACATEROL 65 85% 2% 34
6 ONCE DAILY TIOTROPIUM 59 81% 2% 35
7 ACTING ANTIMUSCARINIC BRONCHODILATOR 56 100% 1% 19
8 ANTICHOLINERGIC BRONCHODILATOR 55 82% 2% 32
9 IPRATROPIUM BROMIDE 54 29% 9% 161
10 BA 679 BR 50 88% 1% 23

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 11% 4% 62

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease - A systematic review and meta-analysis 2008 229 37 54%
Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease 2013 38 72 79%
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives 2015 2 41 61%
Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety 2015 1 31 97%
Novel long-acting bronchodilators for COPD and asthma 2008 77 42 69%
Emerging inhaled bronchodilators: an update 2009 46 39 79%
Olodaterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease 2015 1 9 89%
Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials 2011 92 16 50%
Anticholinergic agents in asthma and COPD 2006 64 26 88%
Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis 2005 89 35 77%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 UNIT P CLIN PHARMACOL 10 44% 1.0% 18
2 P DEV 7 67% 0.3% 6
3 STRITCH LOYOLA MED 6 80% 0.2% 4
4 TA P DIS 6 100% 0.2% 4
5 UNIT PNEUMOL ALLERGOL 5 32% 0.8% 14
6 P MED DEV 5 24% 1.0% 17
7 NUPAIVA ASTHMA 4 67% 0.2% 4
8 UNITA FARMACOL CLIN P 4 56% 0.3% 5
9 EMERGENCIA 3 21% 0.7% 12
10 P IMMUNOINFLAMMAT 3 50% 0.2% 4

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000212094 COPD//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
2 0.0000133718 FORMOTEROL//SALMETEROL//BUDESONIDE FORMOTEROL
3 0.0000118187 PARASYMPATHETIC NERVES//ALLERGIC GUINEA PIGS//ALUMINIA
4 0.0000100149 JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG//NEBULIZER//METERED DOSE INHALER
5 0.0000080892 MULTIFOCAL ATRIAL TACHYCARDIA//CHAOTIC ATRIAL RHYTHM//CHAOTIC ATRIAL TACHYCARDIA
6 0.0000074691 OXATOMIDE//AL 3264//PROCATEROL
7 0.0000073836 STATUS ASTHMATICUS//ACUTE ASTHMA//ACUTE SEVERE ASTHMA
8 0.0000072253 BAMBUTEROL//NOCTURNAL ASTHMA//JAMES B SKATRUD PULM SLEEP
9 0.0000071033 PULMONARY REHABILITATION//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//COPD
10 0.0000064437 AGEING LUNG//SELF REPORTED ASTHMA//CATTEDRA MALATTIE P